DOSSIER · UPDATED 18 NOV 2025

Tome Biosciences

Tome Biosciences is a biotechnology company that develops programmable gene insertion technology. Using CRISPR, its technologies allow them to insert any genetic sequence of any size at any location into any genome.

tome.bio ↗Claim this profile

Founded: 2021
Headcount: 91
Open roles: 0
Last raised: Series A · $213M

SECTION I · THE BRIEF

Inside Tome Biosciences

Brief #93171Updated 18 NOV 2025WATERTOWNGVSERIES A

Employbl Dossier

Tome Biosciences

Founded: 2021
Headcount: 91
Open roles: 0
Last raised: Series A · $213M

Section II — RestrictedMembers only

Engineering interview process at Tome Biosciences
Tech stack & infrastructure choices
Culture & day-to-day work style
Why join now vs. 6 months from now
Hiring focus & open headcount by team
Comp philosophy and band context

Open Tome Biosciences brief Sign in

7-day free trial · $25/mo · cancel anytime

LEADERSHIP

Founders & key people

Omar Abudayyeh

Jonathan Gootenberg

OPEN ROLES

Hiring at Tome Biosciences

Current Job Listings

Listing 0 of 0 job openings

We don't currently have any jobs listed for this company. We suggest visiting the Jobs Search page if you are looking for exciting new tech and startup opportunities.

FUNDING

Capital raised

Total Amount Raised: $213,000,000

Tome Biosciences' Investors

Andreessen Horowitz

Tome Biosciences Funding Rounds

Series A
$213,000,000
Dec 12, 2023
Series A
$213,000,000
Dec 11, 2023
Series A Investors
Longwood Fund
GV
Bruker
Arch Venture Partners
Andreessen Horowitz
Fujifilm Holdings
Polaris Partners
Alexandria Venture Investments